An Argus II Case Report

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jan 2017Publisher:Kare PublishingJournal:Beyoglu Eye Journal (issn: 2459-1777,

Copyright policy )

Authors: İrfan Perente; Gürkan Erdoğan; Muhittin Taşkapılı;

doi: 10.14744/bej.2017.54264

An Argus II Case Report

- Summary
- Subjects
- Metrics

Abstract

The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant. It provides electrical stimulation of the retina and induces visual perception in individuals with low vision. It is used in patients with severe disease, such as retinitis pigmentosa (RP). Presently described is Argus II implantation in a patient with RP.

Related Organizations

Keywords

Ophthalmology, argus 2, retinal implant, retinitis pigmentosa., RE1-994

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average